{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Minneapolis&page=41&state=Minnesota", "query": { "state": "Minnesota", "city": "Minneapolis", "page": 41 }, "page_size": 10 }, "pagination": { "page": 41, "page_size": 10, "total_count": 7866, "total_pages": 787, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Minneapolis&page=42&state=Minnesota&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Minneapolis&page=40&state=Minnesota&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-09T23:29:54.918Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00072683", "title": "\"SALT Trial\" Study of Ascending Levels of Tolvaptan in Hyponatremia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hyponatremias", "Water Intoxication", "Inappropriate ADH Syndrome", "Water-Electrolyte Imbalances" ], "interventions": [ { "name": "tolvaptan", "type": "DRUG" }, { "name": "placebo matching tolvaptan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 205, "start_date": "2003-04-01", "completion_date": "2005-12-01", "has_results": false, "last_update_posted_date": "2026-07-13", "last_synced_at": "2026-11-09T23:29:54.918Z", "location_count": 23, "location_summary": "Los Angeles, California • San Francisco, California • Denver, Colorado + 17 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00072683" }, { "nct_id": "NCT01480479", "title": "Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glioblastoma", "Small Cell Glioblastoma", "Giant Cell Glioblastoma", "Gliosarcoma", "Glioblastoma With Oligodendroglial Component" ], "interventions": [ { "name": "Rindopepimut (CDX-110) with GM-CSF", "type": "DRUG" }, { "name": "Temozolomide", "type": "DRUG" }, { "name": "KLH", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celldex Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 745, "start_date": "2011-11", "completion_date": "2016-11", "has_results": false, "last_update_posted_date": "2018-01-16", "last_synced_at": "2026-11-09T23:29:54.918Z", "location_count": 88, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 74 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01480479" }, { "nct_id": "NCT01078454", "title": "Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Light Chain Deposition Disease", "Primary Systemic Amyloidosis" ], "interventions": [ { "name": "melphalan", "type": "DRUG" }, { "name": "dexamethasone", "type": "DRUG" }, { "name": "bortezomib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2010-11", "completion_date": "2012-11-27", "has_results": true, "last_update_posted_date": "2022-02-01", "last_synced_at": "2026-11-09T23:29:54.918Z", "location_count": 209, "location_summary": "Scottsdale, Arizona • Little Rock, Arkansas • Aurora, Colorado + 140 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01078454" }, { "nct_id": "NCT00742924", "title": "Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Sarcoma" ], "interventions": [ { "name": "cisplatin", "type": "DRUG" }, { "name": "dexrazoxane hydrochloride", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "ifosfamide", "type": "DRUG" }, { "name": "leucovorin calcium", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" }, { "name": "zoledronic acid", "type": "DRUG" }, { "name": "adjuvant therapy", "type": "PROCEDURE" }, { "name": "neoadjuvant therapy", "type": "PROCEDURE" }, { "name": "therapeutic conventional surgery", "type": "PROCEDURE" }, { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "Mesna", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE", "BIOLOGICAL" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "40 Years", "sex": "ALL", "summary": "Up to 40 Years" }, "enrollment_count": 24, "start_date": "2008-08", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-07-04", "last_synced_at": "2026-11-09T23:29:54.918Z", "location_count": 77, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Downey, California + 70 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Downey", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00742924" }, { "nct_id": "NCT03224559", "title": "Applying Neuromodulation to Accelerate Training Effects", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cognition" ], "interventions": [ { "name": "Transcranial Electrical Stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2019-09-01", "completion_date": "2021-05-30", "has_results": false, "last_update_posted_date": "2019-11-12", "last_synced_at": "2026-11-09T23:29:54.918Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03224559" }, { "nct_id": "NCT07789496", "title": "Quit With Sense: Using Mindful Smoking and Wearable Device for Smoking Cessation", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Smoking Cessation", "Cigarette Smoking", "Tobacco Use", "Nicotine Dependence" ], "interventions": [ { "name": "Mindful Smoking and Sensor-Band Intervention", "type": "BEHAVIORAL" }, { "name": "Smoking Cessation Information", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2026-11-10", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-11-09T23:29:54.918Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07789496" }, { "nct_id": "NCT03429803", "title": "DAY101 In Gliomas and Other Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Low-grade Glioma" ], "interventions": [ { "name": "DAY101", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Karen D. Wright, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "25 Years", "sex": "ALL", "summary": "1 Year to 25 Years" }, "enrollment_count": 44, "start_date": "2018-02-27", "completion_date": "2025-12-31", "has_results": false, "last_update_posted_date": "2026-02-19", "last_synced_at": "2026-11-09T23:29:54.918Z", "location_count": 15, "location_summary": "Los Angeles, California • San Diego, California • San Francisco, California + 10 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03429803" }, { "nct_id": "NCT00128713", "title": "Optimal Platelet Dose Strategy for Management of Thrombocytopenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Thrombocytopenia" ], "interventions": [ { "name": "Medium Dose Prophylactic Platelet Transfusions", "type": "PROCEDURE" }, { "name": "Lower Dose Prophylactic Platelet Transfusions", "type": "PROCEDURE" }, { "name": "Higher Dose Prophylactic Platelet Transfusions", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Carelon Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "100 Years", "sex": "ALL", "summary": "Up to 100 Years" }, "enrollment_count": 1351, "start_date": "2004-07", "completion_date": "2008-01", "has_results": true, "last_update_posted_date": "2015-10-28", "last_synced_at": "2026-11-09T23:29:54.918Z", "location_count": 21, "location_summary": "Atlanta, Georgia • Iowa City, Iowa • New Orleans, Louisiana + 14 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00128713" }, { "nct_id": "NCT01305382", "title": "Noninvasive Evaluation of Cardiac Allograft Vasculopathy", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cardiac Allograft Vasculopathy" ], "interventions": [], "intervention_types": [], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2008-10", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2016-11-15", "last_synced_at": "2026-11-09T23:29:54.918Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01305382" }, { "nct_id": "NCT03994796", "title": "Genetic Testing in Guiding Treatment for Patients With Brain Metastases", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "CDK Gene Mutation", "Metastatic Malignant Neoplasm in the Brain", "Metastatic Malignant Solid Neoplasm", "NTRK Family Gene Mutation", "PI3K Gene Mutation", "ROS1 Gene Mutation", "KRAS G12C Mutation" ], "interventions": [ { "name": "Abemaciclib", "type": "DRUG" }, { "name": "PI3K Inhibitor paxalisib", "type": "DRUG" }, { "name": "Entrectinib", "type": "DRUG" }, { "name": "Adagrasib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2019-10-17", "completion_date": "2028-06", "has_results": true, "last_update_posted_date": "2026-10-30", "last_synced_at": "2026-11-09T23:29:54.918Z", "location_count": 435, "location_summary": "Anchorage, Alaska • Phoenix, Arizona • Scottsdale, Arizona + 306 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT03994796" } ] }